7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol has been researched along with luteolin in 1 studies
Studies (7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol) | Trials (7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol) | Recent Studies (post-2010) (7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol) | Studies (luteolin) | Trials (luteolin) | Recent Studies (post-2010) (luteolin) |
---|---|---|---|---|---|
8 | 0 | 0 | 2,402 | 15 | 1,648 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gopalakrishnakone, P; Ignacimuthu, S; Samy, RP | 1 |
1 other study(ies) available for 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol and luteolin
Article | Year |
---|---|
Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Anticarcinogenic Agents; Antioxidants; Body Weight; Catalase; Female; Glutathione Peroxidase; Lipid Peroxides; Luteolin; Mammary Neoplasms, Experimental; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors; Treatment Outcome | 2006 |